Peripheral T-Cell Lymphoma, Not Otherwise Specified – a case report and short literature review
Abstract
Keywords
Full Text:
PDFReferences
Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36(7):1720-1748. PMID: 35732829; PMCID: PMC9214472, doi: 10.1038/s41375-022-01620-2.
Amador C, Greiner TC, Heavican TB, et al. Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry. Blood. 2019; 134(24):2159-2170. PMID: 31562134; PMCID: PMC6908831, doi: 10.1182/blood.2019000779.
Broccoli A, Zinzani PL. Peripheral T-cell lymphoma, not otherwise specified. Blood. 2017; 129(9):1103-1112. PMID: 28115372, doi: 10.1182/blood-2016-08-692566.
Abouyabis AN, Shenoy PJ, Lechowicz MJ, Flowers CR. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma. 2008; 49(11):2099-2107. doi: 10.1080/10428190802455867.
Park HS, McIntosh L, Braschi-Amirfarzan M, Shinagare AB, Krajewski KM. T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes. Korean J Radiol. 2017; 18(1):71-83. PMID: 28096719; PMCID: PMC5240486, doi: 10.3348/kjr.2017.18.1.71.
Zinzani PL, Broccoli A. T-cell lymphoproliferative disorders. In: Hoffbrand V, Higgs DR, Keeling DM, et al, eds. Postgraduate hematology, 7th ed. Hoboken, NJ: Wiley Blackwell; 2016:524–536.
Choudhary S, McLeod M, Torchia D, Romanelli P. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. J Clin Aesthet Dermatol. 2013; 6(6):31-37. PMID: 23882307; PMCID: PMC3718748.
Fox CP, Ahearne MJ, Pettengell R, et al. Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline. Br J Haematol. 2022; 196(3):507-522. PMID: 34811725, doi: 10.1111/bjh.17951.
Gaulard P, de Leval L. Pathology of peripheral T-cell lymphomas: where do we stand? Semin Hematol. 2014; 51(1):5-16. PMID: 24468311, doi: 10.1053/j.seminhematol.2013.11.003.
d’Amore F, Gaulard P, Trümper L, et al. Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015; 26 Suppl 5:v108-115. PMID: 26314772,
doi: 10.1093/annonc/mdv201.
Moon SH, Cho SK, Kim WS, et al. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods. J Nucl Med. 2013; 54(7):1039-1044. PMID: 23658217, doi: 10.2967/jnumed.112.113399.
Zhang XM, Li YX, Wang WH, et al. Survival advantage with the addition of radiation therapy to chemotherapy in early-stage peripheral T-cell lymphoma, not otherwise specified. Int J Radiat Oncol Biol Phys. 2013; 85(4):1051-1056. PMID: 23021436, doi: 10.1016/j.ijrobp.2012.08.015.
Siegert W, Agthe A, Griesser H, et al. Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. Ann Intern Med. 1992; 117(5):364-370. PMID: 1380221, doi: 10.7326/0003-4819-117-5-364.
Horwitz S, O’Connor OA, Pro B, et al. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Lancet. 2019; 393(10168):229-240. doi: 10.1016/S0140-6736(18)32984-2. Erratum in: Lancet. 2019; 393(10168):228. PMID: 30522922; PMCID:
PMC6436818.
Bachy E, Camus V, Thieblemont C, et al. Romidepsin Plus CHOP versus CHOP in patients with previously untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA). J Clin Oncol. 2022; 40(3):242-251. PMID: 34843406, doi: 10.1200/JCO.21.01815.
Gutiérrez-García G, García-Herrera A, Cardesa T, et al. Comparison of four prognostic scores in peripheral T-cell lymphoma. Ann Oncol. 2011; 22(2):397-404. PMID: 20631009, doi: 10.1093/annonc/mdq359.
Mak V, Hamm J, Chhanabhai M, et al. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. J Clin Oncol. 2013; 31(16):1970-1976. PMID: 23610113, doi: 10.1200/JCO.2012.44.7524.
DOI: http://dx.doi.org/10.22551/2022.37.0904.10220
Copyright (c) 2022 Rafael Henriques Figueiredo, Beatriz Simao Parreira, Pedro Amoroso Canao, Leila Cardoso, Elsa Fonseca, Jorge Almeida
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ISSN: 2360-6975